Eclipsing Toxicity, Enhancing Efficacy: Clofazimine’s Vanguard in the Realm of Anti-PD-1 and CTLA-4 Immunotherapy

• Ruirong Tan,
• Junning Zhao,
• Quazi T. H. Shubhra

Affiliations

Ruirong Tan

Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu 610041, China.

Junning Zhao

Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu 610041, China.

Quazi T. H. Shubhra

Institute of Chemistry, University of Silesia in Katowice, Szkolna 9, 40-003 Katowice, Poland.